A carregar...
Neoadjuvant immunotherapy for muscle invasive urothelial bladder carcinoma: will it change current standards?
Immunotherapy, in the form of immune checkpoint inhibitors (ICI), has shown activity in metastatic urothelial bladder carcinoma, resulting in the approval of several ICI agents in the first- and second-line settings. This has led to an increased interest in studying their efficacy in the neoadjuvant...
Na minha lista:
| Publicado no: | Ther Adv Urol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8273398/ https://ncbi.nlm.nih.gov/pubmed/34290827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17562872211029779 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|